Evaluation Core

评估核心

基本信息

  • 批准号:
    10707078
  • 负责人:
  • 金额:
    $ 128.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY EVALUATION CORE NeuroTech Harbor's (NTH) Evaluation Core (EC) is a critical element of the NTH. The EC will be responsible for providing thorough, timely evaluations of a large number of innovator proposals and identify those few that have a high potential for clinical impact and commercial viability. In addition, the EC will identify gaps in proposals that help innovators improve, as well as guide future steps on reapplying to NTH or other BP Hubs. The EC must not only ensure that the need addressed in a proposal is significant, but also that a feasible plan is viable and laid out to achieve deliverables, including resources required. Since NTH will receive a broad range of applications, the EC will recruit top experts to adequately evaluate proposals. Finally, the EC will recruit experts from diverse backgrounds, a core value of NeuroTech Harbor. Lastly the EC will assess and provide guidance in ways innovators can increase the potential for commercial success globally by expanding their impact to under-served communities. To help manage this complex task, the NTH EC will leverage the Consortia for Improving Medicine with Innovation & Technology's (CIMIT's) Guidance and Impact Tracking (GAITS) web-based platform to (i) help innovators prepare competitive proposals, and (ii) provide a methodology for all EC panels, especially the Deep- Dive panel, to assess subproject proposals with consistent criteria. The EC will provide applicants and panel members with basic training on how to use the GAITS platform. To recruit diverse specialists covering topics of all submitted proposals to serve on our evaluation panels, the EC will work with NTH's Consultant Network, and leverage The LaunchPort, a MedTech manufacturing accelerator, with an extensive network of diverse experts. The EC aims are: (Aim 1) To implement a rigorous, unbiased, and efficient evaluation process that identifies neuromedical solutions with high potential for commercial success and clinical benefit. (Aim 2) To deploy a proposal management platform to facilitate evaluation of subproject and subaward proposals as well as preparation of proposals. (Aim 3) To facilitate building a pipeline of diverse aspiring innovators. The evaluation process is inspired by the RADx model and the NIH peer review system and will include industry experts who will appraise the feasibility of the total lifecycle of proposed solutions. Evaluation will occur in three stages: Triage, Viability, and Deep Dive. Short preproposals will be evaluated during Triage, and full proposals will be evaluated during Viability and Deep Dive. Full proposals will be assessed using GAITS criteria and NTH's new equity & accessibility criteria. The Deep Dive stage will involve intensive interaction and multiple feedback cycles with proposers and reviewer. To facilitate evaluation and management of subproject and subaward proposals, NeuroTech Harbor, in partnership with VentureWell (VW), will provide an online portal for applicants to submit their applications and for reviewers from the EC, Steering Committee, and NIH personnel to review and comment on proposals.
项目总结评价核心 Neurotech Harbor(Nth)评估核心(EC)是Nth的关键要素。欧委会将负责 为大量创新者提案提供彻底、及时的评估,并确定那些 具有很高的临床影响和商业潜力。此外,教统会将找出建议中的漏洞 这有助于创新者改进,并指导未来重新应用于第n或其他BP枢纽的步骤。欧共体必须 不仅要确保提案中解决的需求是重要的,而且要确保可行的计划是可行的,并且 为实现可交付成果而布局,包括所需的资源。因为第n个人将获得广泛的 对于申请,欧委会将聘请顶尖专家对提案进行充分评估。最后,欧委会将招募专家 来自不同背景,Neurotech Harbor的核心价值观。最后,欧委会将评估并提供指导 创新者可以通过扩大他们的影响力来增加全球商业成功的潜力 服务不足的社区。 为了帮助管理这项复杂的任务,第n个欧共体将利用该财团改善医学与 创新科技(CIMIT)的指导和影响跟踪(步态)基于网络的平台,以(I)帮助 创新者准备有竞争力的建议,以及(Ii)为所有EC小组提供一种方法,特别是深水- 潜水小组,以一致的标准评估子项目提案。欧委会将提供申请者和评审团 接受过如何使用步态平台的基本培训的成员。招聘不同的专家,涵盖以下主题 所有提交的提案将在我们的评估小组中提供服务,欧委会将与第N个的顾问网络合作,以及 利用医疗科技制造加速器LaunchPort,以及由不同专家组成的广泛网络。 欧共体的目标是:(目标1)实施严格、公正和有效的评估过程,以确定 具有很高商业成功潜力和临床效益的神经医学解决方案。(目标2)部署一支 提案管理平台,以促进子项目和子奖励提案的评估以及 拟备建议书。(目标3)促进建立各种有抱负的创新者的渠道。评估 流程的灵感来自RADx模型和NIH同行审查系统,并将包括以下行业专家 将评估所提议的解决方案的整个生命周期的可行性。评估将分三个阶段进行:分类, 生存能力和深度潜水。简短的预先建议将在分流期间进行评估,完整的建议将进行评估 在生存能力和深度潜水期间。完整的提案将使用步态标准和第N TH的新股权进行评估 可访问性标准。深潜阶段将包括密集的互动和多个反馈周期 提出者和审查者。为便利评价和管理次级项目和次级奖励提案, Neurotech Harbor与VentureWell(大众)合作,将提供一个在线门户,供申请者提交 他们的申请,以及来自欧盟委员会、指导委员会和NIH人员的审查员审查和评论 关于提案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Youseph Yazdi其他文献

Youseph Yazdi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

OncoPath: Intelligent Clinical Pathway Decision Support Tool for Pre-Authorization Documentation in Non-Small Cell Lung Cancer Treatment
OncoPath:用于非小细胞肺癌治疗预授权文档的智能临床路径决策支持工具
  • 批准号:
    10325551
  • 财政年份:
    2021
  • 资助金额:
    $ 128.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了